LAVA Therapeutics N.V. (LVTX)

LAVA Therapeutics Statistics

Total Valuation

LVTX has a market cap or net worth of $40.25 million. The enterprise value is -$15.92 million.

Market Cap	40.25M
Enterprise Value	-15.92M

Important Dates

The last earnings date was Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

LVTX has 26.31 million shares outstanding. The number of shares has decreased by -0.42% in one year.

Current Share Class	26.31M
Shares Outstanding	26.31M
Shares Change (YoY)	-0.42%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	0.42%
Owned by Institutions (%)	8.47%
Float	10.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.24
Forward PS	n/a
PB Ratio	2.02
P/TBV Ratio	2.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.78

Current Ratio	10.78
Quick Ratio	10.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-56.95

Financial Efficiency

Return on equity (ROE) is -90.20% and return on invested capital (ROIC) is -53.05%.

Return on Equity (ROE)	-90.20%
Return on Assets (ROA)	-23.94%
Return on Invested Capital (ROIC)	-53.05%
Return on Capital Employed (ROCE)	-53.29%
Revenue Per Employee	$146,765
Profits Per Employee	-$833,176
Employee Count	34
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

In the past 12 months, LVTX has paid $773,000 in taxes.

Income Tax	773,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.47% in the last 52 weeks. The beta is 0.49, so LVTX's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	-15.47%
50-Day Moving Average	1.39
200-Day Moving Average	1.31
Relative Strength Index (RSI)	59.72
Average Volume (20 Days)	155,712

Short Selling Information

The latest short interest is 37,214, so 0.14% of the outstanding shares have been sold short.

Short Interest	37,214
Short Previous Month	51,706
Short % of Shares Out	0.14%
Short % of Float	0.36%
Short Ratio (days to cover)	0.76

Income Statement

In the last 12 months, LVTX had revenue of $4.99 million and -$28.33 million in losses. Loss per share was -$1.05.

Revenue	4.99M
Gross Profit	-19.56M
Operating Income	-29.27M
Pretax Income	-28.31M
Net Income	-28.33M
EBITDA	-28.96M
EBIT	-29.27M
Loss Per Share	-$1.05

Balance Sheet

The company has $56.17 million in cash and n/a in debt, giving a net cash position of $56.17 million or $2.14 per share.

Cash & Cash Equivalents	56.17M
Total Debt	n/a
Net Cash	56.17M
Net Cash Per Share	$2.14
Equity (Book Value)	19.94M
Book Value Per Share	0.76
Working Capital	54.88M

Cash Flow

Operating Cash Flow	-35.71M
Capital Expenditures	n/a
Free Cash Flow	-35.71M
FCF Per Share	-$1.36

Margins

Gross Margin	n/a
Operating Margin	-586.63%
Pretax Margin	-552.20%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LVTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.42%
Shareholder Yield	0.42%
Earnings Yield	-70.39%
FCF Yield	-88.73%

Analyst Forecast

The average price target for LVTX is $1.58, which is 3.27% higher than the current price. The consensus rating is "Hold".

Price Target	$1.58
Price Target Difference	3.27%
Analyst Consensus	Hold
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-22.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1